Increasing evidence has suggested that aberrant methylation of the DAPK promoter, which leads to its silencing, is responsible for the initiation and progression of NPC through the regulation of many signaling pathways, including apoptosis, autophagy, and immune responses [15,16]. Here, DAPK1 is linked to nasopharyngeal carcinoma.